Published: February 20, 2026 at 8:45 am
A recently appointed board member at SkinBioTherapeutics will oversee a ‘forensic’ investigation into the actions of the former CEO at the listed company.
Alyson Levett was only appointed to the board and as chair of its audit committee in January and will oversee the probe into former CEO Stuart Ashman, who resigned recently amid accusations of misrepresenting results.
The Newcastle firm has shed 72% of its value since the news broke, while it is down 8% in the opening 30 minutes of trading today following the news that Levett will lead the investigation on behalf of the board, which has also appointed FRP Advisory for the job.
Existing external legal and professional advisers will also support the process, as necessary, it said.
Levett has over 20 years C-suite financial experience, culminating in being CFO at the strategy software company, i-nexus where she stayed for a decade taking it onto AIM in a successful IPO in 2018.